Council Decision (EU) 2024/832 of 4 March 2024 on the position to be taken on behalf of the European Union in the 67th session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971

• CELEX: Decision (EU) 2024/832
• Articles: 4

Article 1

The position to be taken on behalf of the Union by the Member States in the 67th session of the Commission on Narcotic Drugs taking place from 14 to 22 March 2024, as regards the adoption of decisions on the addition of substances to the Schedules of the United Nations Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the United Nations Convention on Psychotropic Substances of 1971, shall be in accordance with that set out in the Annex to this Decision.

Article 2

The position referred to in Article 1 shall be expressed by the Member States that are members of the Commission on Narcotic Drugs, acting jointly in the interest of the Union.

Article 3

This Decision shall enter into force on the date of its adoption.

Schedules & Appendices

ANNEX

ANNEX

Position to be taken by the Member States that are members of the Commission on Narcotic Drugs, acting jointly , in the interest of the Union, during the 67th session of the Commission on Narcotic Drugs from 14 to 22 March 2024 on the scheduling of substances:

(1)

Bromazolam is to be included in Schedule IV of the Convention on Psychotropic Substances;

(2)

Butonitazene is to be included in the Schedule I of the Convention on Narcotic Drugs;

(3)

3-Chloromethcathinone (3-CMC) is to be included in Schedule II of the Convention on Psychotropic Substances;

(4)

Dipentylone is to be included in Schedule II of the Convention on Psychotropic Substances;

(5)

2-Fluorodeschloroketamine (2-FDCK) is to be included in Schedule II of the Convention on Psychotropic Substances.